Newborn screening study taps Revvity for genome sequencing
Revvity to work with Early Check, a groundbreaking research study that provides free voluntary health tests for newborns
Source: selectscience.net
Early Check News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Early Check. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Early Check Today - Breaking & Trending Today
Are We Ready for Systematic Newborn Genome Sequencing?
Routine sampling and analysis of newborn DNA would enable screening for hundreds of childhood genetic diseases, but also raises concerns about privacy and ethics.
Source: medscape.com
How Genome Sequencing Can Broaden the Scope of Newborn Screening
Standard newborn screening can detect dozens of inherited diseases, but genomics technology enables testing for hundreds of them. A North Carolina program evaluating the feasibility of bringing genomics to newborn screening is expanding with an initial goal of testing 5,000 babies in the next year.
Source: medcitynews.com
Spinal Muscular Atrophy Treatment Market Worth $18.0 Billion by 2030: Grand View Research, Inc.
SAN FRANCISCO, Jan. 11, 2023 /PRNewswire/ -- The global spinal muscular atrophy treatment market size is expected to reach USD 18.0 billion by 2030, according to a new study by Grand View
Source: finanznachrichten.de
Spinal Muscular Atrophy Treatment Market Report 2022:
Dublin, Dec. 23, 2022 (GLOBE NEWSWIRE) -- The "Spinal Muscular Atrophy Treatment Market Size, Share & Trends Analysis Report By Type (Type1, Type 2),...
Source: globenewswire.com